Results 231 to 240 of about 53,424 (299)

Genotoxicity  effects in Cancer Patients: Evaluation by Micronucleus and Comet Assays and Correlation with Biochemical and Hematological Indices. [PDF]

F1000Res
Dalaf Khalaf S, Talal Mahmood A, Fadhil Abbas A, Watheq Neamah R, Nasser Abdul Hameed R.   +4 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

What Drives Indonesian People to Purchase Modest Fashion? The Moderating Role of Religiosity. [PDF]

F1000Res
Fathoni MA, Sholihah DR, Wulansari AS.
europepmc   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

Molecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

ERGA-BGE chromosome-level genome assembly of the giant stream lacewing  <i>Osmylus fulvicephalus</i> (Scopoli, 1763). [PDF]

Open Res Eur
Maurstad MF, Kusy D, Undheim EAB, Jakobsen KS, Böhne A, Monteiro R, Marcussen T, Struck TH, Oomen RA, Bunikis I, Tellgren-Roth C, Heintz J, Häggqvist S, Jonsäll L, Lager N, Larva T, Mosbech MB, Pippel M, Vinnere Pettersson O, Bortoluzzi C.   +19 more
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Understanding possible differences between haemodialysis and haemodiafiltration which affect survival in end-stage kidney disease dialysis patients: the STITCHED study halted by the COVID-19 epidemic. [PDF]

NIHR Open Res
Davenport A, MacNeil S, Caskey F.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

EUPopLink Country report - Estonia. [PDF]

Open Res Eur
Kutnarová P.
europepmc   +1 more source

VAR consultation patterns and their association with fouls and misconduct: An analysis of the top five European football leagues. [PDF]

PLoS One
Nazarudin MN, P P Abdul Majeed A, Musa RM, Raj NB, Kuan G, Abu Osman NA.   +5 more
europepmc   +1 more source